-
公开(公告)号:US07592467B2
公开(公告)日:2009-09-22
申请号:US11400582
申请日:2006-04-07
IPC分类号: C07D333/12 , C07D333/22 , C07D307/46 , A61K31/341 , A61K31/381
CPC分类号: C07D409/12 , C07D307/46 , C07D333/22 , C07D333/56
摘要: The present invention relates to novel inhibitors of prolyl endopeptidase of formula (1) wherein I, A, X, Y and Z are specified in the description. The compounds are useful for the treatment of diseases such as mild cognitive impairment (MCI), Alzheimer's disease, Down Syndrome, Parkinson disease and Chorea Huntington.
摘要翻译: 本发明涉及式(1)的脯氨酰内肽酶的新型抑制剂,其中I,A,X,Y和Z在说明书中具体规定。 该化合物可用于治疗诸如轻度认知障碍(MCI),阿尔茨海默病,唐氏综合症,帕金森病和霍乱金淋巴瘤等疾病。
-
公开(公告)号:US20060229357A1
公开(公告)日:2006-10-12
申请号:US11400582
申请日:2006-04-07
IPC分类号: A61K31/381 , A61K31/34 , C07D333/22 , C07D307/02
CPC分类号: C07D409/12 , C07D307/46 , C07D333/22 , C07D333/56
摘要: The present invention relates to novel inhibitors of prolyl endopeptidase of formula (1) wherein I, A, X, Y and Z are specified in the description. The compounds are useful for the treatment of diseases such as mild cognitive impairment (MCI), Alzheimer's disease, Down Syndrome, Parkinson disease and Chorea Huntington.
摘要翻译: 本发明涉及式(1)的脯氨酰内肽酶的新型抑制剂,其中I,A,X,Y和Z在说明书中具体规定。 该化合物可用于治疗诸如轻度认知障碍(MCI),阿尔茨海默病,唐氏综合症,帕金森病和霍乱金淋巴瘤等疾病。
-